Acetylfentanyl

COPD, sleep apnea, pneumonia, asthma exacerbation, restrictive lung disease

Acetylfentanyl's primary lethal mechanism is respiratory depression. Any pre-existing respiratory compromise — COPD, sleep apnea, pneumonia, asthma exacerbation — creates additive or synergistic depression of respiratory drive. The compound's narrow therapeutic index (LD50/ED50 ≈ 443, 23× narrower than fentanyl) leaves no safety margin in individuals with baseline respiratory impairment.

traumatic brain injury, intracranial mass lesion, hydrocephalus

MOR agonism-mediated respiratory depression reduces respiratory rate and tidal volume, causing hypercapnia. CO2 retention triggers cerebral vasodilation, which can exacerbate intracranial hypertension in patients with head injury, space-occupying lesions, or pre-existing elevated ICP.

cirrhosis, hepatic insufficiency, acute liver failure

Acetylfentanyl is presumed to undergo CYP3A4-mediated N-dealkylation by structural analogy to fentanyl. Hepatic impairment would reduce metabolic clearance, prolonging plasma concentrations and potentiating respiratory depression. No acetylfentanyl-specific hepatic metabolism or CYP phenotyping data exist.

pregnancy, breastfeeding

All mu-opioid receptor agonists cross the placental barrier. Chronic exposure during pregnancy produces physical dependence in the fetus, resulting in neonatal opioid withdrawal syndrome upon delivery. No acetylfentanyl-specific reproductive or teratogenicity data exist; contraindication is inferred from opioid class pharmacology.

benzodiazepines, alcohol, GHB, GBL, barbiturates, other opioids, sedative-hypnotics

Co-administration with benzodiazepines, alcohol, GHB/GBL, barbiturates, or other opioids produces lethal synergistic respiratory depression. In the Pennsylvania fatality series (n=41), 96% of acetylfentanyl deaths involved multiple drugs. A documented case involved alprazolam at toxic concentration (64.9 µg/L) alongside acetylfentanyl (32.9 µg/L) and fentanyl.

opioid-naïve status, tolerance mismatch

The exceptionally narrow therapeutic index means the margin between an effective and a lethal dose is smaller with acetylfentanyl than with most other opioids. Opioid-naïve individuals receiving doses calibrated for tolerant users face extreme overdose risk. No quality-controlled dosage forms or established clinical dosing guidelines exist.